Human Eosinophil-Lymphocyte Interactions

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 173-182

  Weller, Peter F ^a   Lim, Kaiser ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allergic disorders; Human eosinophil; Lymphocite interactions

Indexed keywords

CYTOKINE;

CELL COMMUNICATION; EOSINOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE; PHYSIOLOGY; REVIEW;

CELL COMMUNICATION; CYTOKINES; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTES;

EID: 0031311292     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800023     Document Type: Article

References (119)

1. Abraham WM, Sielczak MW, Ahmed A, Cortes A, Lauredo IT, Kim J, Pepinsky B, Benjamin CD, Leone DR, Lobb RR, Weller PF 1994. Anti-α4 intergrin mediates antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 93: 776-787.
2. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ 1989. IgA-induced eosinophil degranulation. J Immunol 142: 2393-2400.
3. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT 1993. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol 150: 3109-3118.
4. Aiello FB, Longo DL, Overton R, Takacs L, Durum SK 1990. A role for cytokines in antigen presentation: IL-1 and IL-4 induce accessory functions of antigen-presenting cells. J Immunol 144: 2572-2581.
5. Beil WJ, Weller PF, Tzizik DM, Galli SJ, Dvorak AM 1993. Ultrastructural immunogold localization of tumor necrosis factor to the matrix compartment of human eosinophil secondary granules. J Histochem Cytochem 41: 1611-1615.
6. Beninati W, Derdak S, Dixon PF, Grider DJ, Strollo DC, Hensley RE, Lucey DR 1993. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol 92: 442-449.
7. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am J Respir Cell Mol Biol 8: 35-42.
8. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, Weissman IL, Hamann A, Butcher EC 1993. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185.
9. Bochner BS, Luscinskas FW, Gimbrone MAJ, Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, Schleimer RP 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 173: 1553-1557.
10. Bosse M, Audette M, Ferland C, Pelletier G, Chu HW, Dakhama A, Lavigne S, Boulet LP, Laviolette M 1996. Gene expression of interleukin-2 in purified human peripheral blood eosinophils. Immunology 87: 149-154.
11. Braun RK, Franchini M, Erard F, Rihs S, De Vries IJM, Blaser K, Hansel TT, Walker C 1993. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 23: 956-960.
12. Broide DH, Paine MM, Firestein GS 1992. Eosinophils express interleukin 5 and granulocyte macrophagecolony- stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 141-1424.
13. Butterworth AE 1984. Cell-mediated damage to helminths. Adv Parasitol 23: 143-235.
14. Capron M, Truong MJ, Aldebert D, Gruart V, Suemura M, Delespesse G, Tourvieille B, Capron A 1992. Eosinophil IgE receptor and CD23. Immunol Res 11: 252-259.
15. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T- T help via APC activation. J Exp Med 184: 747-752.
16. Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, Frankel LR, DeKruyff RH, Umetsu DT 1995. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 95: 1415-1421.
17. Chihara J, Kubo H, Sakurada R, Yamamoto J, Nakano N, Sugihara R, Nakajima S 1989. [IgE-Fc receptor expressions on bronchoalveolar lavage (BAL) cells in a patient with eosinophilic pneumonia accompanied with bronchial asthma-the effect of ketotifen on their expression]. Arerugi 38: 326-333.
18. Costa JJ, Matossian K, Beil WJ, Wong DTW, Gordon JR, Dvorak AM, Weller PF, Galli SJ 1993. Human eosinophils can express the cytokines TNF-α and MIP-1α. J Clin Invest 91: 2673-2684.
19. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 183: 1303-1310.
20. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H 1994. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 91: 5109-5113.
21. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, Center DM 1996. IL-16 inhibition of CDS-dependent lymphocyte activation and proliferation. J Immunol 157: 5240-5248.
22. Czech W, Krutmann J, Budnik A, Schopf E, Kapp A 1993. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 100: 417-423.
23. Del Pozo V, De Andrés B, Martin E, Cárdaba B, Fernández JC, Gallardo S, Tramón P, Leyva-Cobian F, Palomino P, Lahoz C 1992. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 22: 1919-1925.
24. Desreumaux P, Janin A, Colombel JF, Prin L, Plumas J, Emiliee D, Torpier G, Capron A, Capron M 1992. Interleukin-5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 175: 293-296.
25. Desvaux FX, Peltre G, David B 1989. Characterization of grass pollen-specific IgE, IgA, IgM classes and IgG subclasses in allergic patients. Int Arch Allergy Appl Immunol 89: 281-287.
26. Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer, R, Zacchi T, Harlan JM, Patriarca P 1991. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 88: 20-26.
27. Elices MJ, Osbom L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 60: 577-584.
28. 1 mRNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93: 864-876.
29. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazorovits AI, Tidswell M 1994. Expression and function of the MAdCAM-1 receptor, integrin α4β7, on human leukocytes. J Immunol 153: 517-528.
30. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201.
31. Gant VA, Shakoor Z, Hamblin AS 1992. A new method for measuring clustering in suspension between accessory cells and T lymphocytes. J Immunol Methods 156: 179-189.
32. Gleich GJ, Adolphson CR, Leiferman KM 1992. Eosinophils, p. 663-700. In Inflammation: basic principles and clinical correlates. 2nd ed., New York, Raven Press.
33. Gosselin EJ, Wardwell K, Gosselin DR, Alter N, Fisher JL, Guyre PM 1992. Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J Immunol 149: 3477-3481.
34. Gounni AS, Lamkhioued B, Delaporte E, Dubost A, Kinet JP, Capron A, Capron M 1994a. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J Allergy Clin Immunol 94: 1214-1216.
35. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M 1994b. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367: 183-186.
36. Grangette C, Gruart V, Ouaissi MA, Rizvi F, Delespesse G, Capron A, Capron M '1989. IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule. J Immunol 143: 3580-3588.
37. Guida L, O'Hehir RE, Hawrylowicz CM 1994. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 84: 2733-2740.
38. Hamid Q, Barkans J, Meng Q, Ying S, Abrams JS, Kay AB, Moqbel R 1992. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 80: 1496-1501.
39. Hansel TT, Braunstein JB, Walker C, Blaser K, Bruijnzeel PLB, Virchow JC Jr, Virchow C 1991. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 86: 271-277.
40. Hansel TT, De Vries IJM, Carballido JM, Braun RK, Carballido-Perrig N, Rihs S, Blaser K, Walker C 1992. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol 149: 2130-2136.
41. Harding CV, Unanue ER 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 574-576.
42. Hartnell A, Kay AB, Wardlaw AJ 1992. IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol 148: 1471-1478.
43. Havenith CE, van Miert PP, Breedijk AJ, Beelen RH, Hoefsmit EC 1993. Migration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am J Respir Cell Mol Biol 9: 484-488.
44. Herndon FJ, Kayes SG 1992. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol 149: 3642-3647.
45. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 177: 397-407.
46. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB 1996. High-affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Resp Crit Care Med 153: 1931-1937.
47. + T cells. J Exp Med 177: 573-576.
48. Kayes SG, Oaks JA 1978. Development of the granulomatous response in murine toxocariasis. Initial events. Am J Pathol 93: 277-294.
49. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ 1991. Granulocyte/macrophage colonystimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 174: 745-748.
50. Kitani S, Ito K, Miyamoto T 1985. IgG, IgA, and IgM antibodies to mite in sera and sputa from asthmatic patients. Ann Allergy 55: 612-620.
51. Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus- lining cells in the spleen. Am J Pathol 147: 763-771.
52. Lamkhioued B, Aldebert D, Gounni AS, Delaporte E, Goldman M, Capron A, Capron M 1995. Synthesis of cytokines by eosinophils and their regulation. Int Arch Allergy Immunol 107: 122-123.
53. + T cells by transforming growth factor-β1. J Immunol 151: 668-677.
54. Levi-Schaffer F, Barkans J, Newman TM, Ying S, Wakelin M, Hohenstein R, Barak V, Lacy P, Kay AB, Moqbel R 1996. Identification of interleukin-2 in human peripheral blood eosinophils. Immunology 87: 155-161.
55. Lim K, Wan H-C, Resnick M, Wong DTW, Cruikshank WW, Kornfeld H, Center DM, Weller PF 1995. Human eosinophils release the lymphocyte and eosinophil active cytokines, RANTES and lymphocyte chemoattractant factor (LCF). Int Arch Allergy Immunol 107: 342.
56. Lim KG, Wan H-C, Bozza PT, Resnick MB, Wong DTW, Cruikshank DTW, Kornfeld H, Center DM, Weller PF 1996a. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor, LCF) and RANTES. J Immunol 156: 2522-2527.
57. Lim KG, Wan HC, Geha R, Weller PF 1996b. Accessory cell function of eosinophils: CD40-mediated T cell proliferation. Am J Respir Crit Care Med 153: A55.
58. Litt M 1963. Studies of experimental eosinophilia. V. Eosinophils in lymph nodes of guinea pigs following primary antigenic stimulation. Am J Pathol 42: 529-550.
59. Litt M 1964a. Studies in experimental eosinophilia VI. Uptake of immune complexes by eosinophils. J Cell Biol 23: 355-361.
60. Litt M 1964b. Studies in experimental eosinophilia VII. Eosinophils in lymph nodes during the first 24 hr following primary antigenic stimulation. J Immunol 93: 807-813.
61. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF 1989a. Human eosinophils express CD4 protein and bind HIV-1 GP120. J Exp Med 169: 327-332.
62. Lucey DR, Nicholson-Weller A, Weller PF 1989b. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 86: 1348-1351.
63. MacLean JA, Xia W, Pinto CE, Zhao L, Liu H-W, Kradin RL 1996. Sequestration of inhaled particulate antigens by lung phagocytes. A mechansism for the effective inhibition of pulmonary cell-mediated immunity. Am J Pathol 148: 657-666.
64. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G 1995. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 154: 6285-6290.
65. Melani C, Mattia GF, Silvani A, Care A, Rivoltini L, Parmiani G, Colombo MP 1993. Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood 81: 2744-2749.
66. Mengelers HJ, Maikoe T, Brinkman L, Hooibrink B, Lammers J-WJ, Koenderman L 1994. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 149: 345-351.
67. Mengelers HJ, Maikoe T, Raaijmakers JA, Lammers JW, Koenderman L 1995. Cognate interaction between human lymphocytes and eosinophils is mediated by beta 2-integrins and very late antigen-4. J Lab Clin Med 126: 261-268.
68. Minami Y, Kono T, Miyaki T, Taniguchi T 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11: 245-268.
69. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H 1993. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 92: 1681-1685.
70. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, Kay AB 1991. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 174: 749-752.
71. Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham SR, Kay AB 1995. Identification of mesenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 155: 4939-4947.
72. Muñoz M, Serrador J, Sánchez-Madrid F, Teixidó J 1996. A region of the integrin VLAα4 subunit involved in homotypic cell aggregation and in fibronectin but not vascular cell adhesion molecule-1 binding. J Biol Chem 271: 2696-2702.
73. Nonaka M, Nonaka R, Woolley K, Adelroth E, Miura K, Okhawara Y, Glibetic M, Nakano K, O'Byrne P, Dolovich J, Jordana M 1995. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 155: 3234-3244.
74. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J, Croitoru K, Weller PF, Jordana M 1996. CD40 expression by human peripheral blood eosinophils. J Clin Invest 97: 1761-1766.
75. Ohkawara Y, Yamauchi K, Maruyama N, Hoshi H, Ohno I, Honma M, Tanno Y, Tamura G, Shirato K, Ohtani H 1995. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am J Respir Cell Mol Biol 12: 4-12.
76. Ohnishi T, Kita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ, Busse WW, Abrams JS, Gleich GJ 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Resp Dis 147: 901-907.
77. Ohno I, Lea R, Finotto S, Marshall J, Denburg J, Dolovich J, Gauldie J, Jordana M 1991. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 5: 505-510.
78. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J, Harley CB, Gauldie J, Jordana M 1992. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta I). J Clin Invest 89: 1662-1668.
79. Okubo Y, Hossain M, Kai R, Sato E, Honda T, Sekiguchi, M, Itoh S, Takatsu K 1995. Adhesion molecules on eosinophils in acute eosinophilic pneumonia. Am J Respir Crit Care Med 151: 1259-1262.
80. Peng X, Kasran A, Warmerdam PA, de Boer M, Ceuppens JL 1996. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Eur J Immunol 26: 1621-1627.
81. Platt-Mills TAE 1992. Mechanisms of bronchial reactivity: the role of immunoglobulin E. Am Rev Resp Dis 145: S44-S7.
82. Platts-Mills TA 1979. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 122: 2218-2225.
83. Pretolani M, Ruffie C, Lapa e Silva JR, Joseph D, Lobb RR, Vargaftig BB 1994. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 180: 795-805.
84. Rand TH, Cruikshank WW, Center DM, Weller PF 1991a. CD4-mediated stimulation of human eosinophils: Lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med 173: 1521-1528.
85. Rand TH, Silberstein DS, Kornfeld H, Weller PF 1991b. Human eosinophils express functional interleukin 2 receptors. J Clin Invest 88: 825-832.
86. Resnick MB, Weller PF 1993. Mechanisms of eosinophil recruitment. Am J Resp Cell Mol Biol 8: 349-355.
87. Roberts AN 1966. Cellular localization and quantitation of tritiated antigen in mouse lymph nodes during early primary immune response. Am J Pathol 49: 889-909.
88. Rott LS, Briskin MJ, Andrew DP, Berg EL, Butcher EC 1996. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal cell adhesion molecule-1. J Immunol 156: 3727-3736.
89. Ruppert J, Peters JH 1991. IL-6 and IL-1 enhance the accessory activity of human blood monocytes during differentiation to macrophages. J Immunol 146: 144-149.
90. Sabesin SM 1963. A function of the eosinophil: phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol Med 112: 667-671.
91. Sabin EA, Kopf MA, Pearce EJ 1996. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 184: 1871-1878.
92. Sakamoto S, Oki K, Takahashi H, Arakawa Y, Sugita H, Kawabata Y, Takeuchi K, Tomichi N 1995a. Surface antigens on eosinophils in bronchial asthma and eosinophilic pneumonia. Int Arch Allergy Immunol 108 (Suppl 1): 6-8.
93. Sakamoto S, Oki K, Takahashi Y, Arakawa Y, Kawata Y, Takeuchi K, Tomichi N 1995b. Surface antigens of eosinophils in peripheral blood and BALF of patients with eosinophilic pneumonia. Am Rev Resp Crit Care Med 151: A219.
94. Schall TJ, Bacon K, Toy KJ, Goeddel DV 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
95. + memory T cells with hallmarks of gut-trophism. J Immunol 151: 717-729.
96. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, McAllister PK, Busse WW 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 149: 3710-3718.
97. Sedgwick JB, Quan SF, Calhoun WJ, Busse WW 1995. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy Clin Immunol 96: 375-385.
98. Sher A, Coffman RL, Hieny S, Cheever AW 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 145: 3911-3916.
99. Tamura N, Ishii N, Nakazawa M, Nagoya M, Yoshinari M, Amano T, Nakazima H, Minami M 1996. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand J Immunol 44: 229-238.
100. Tanaka Y, Takenaka M, Matsunaga Y, Okada S, Anan S, Yoshida H, Ra C 1995. High affinity IgE receptor (Fc epsilon RI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis. Arch Dermatol Res 287: 712-717.
101. + T cells in response to MIP-1α and MIP-1β. Science 260: 355-358.
102. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ 1996. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 59: 81-89.
103. Urban JF, Madden KB, Svetic A, Cheever A, Trotta PP, Gausse WC, Katona IM, Finkelman FD 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 127: 205-220.
104. van der Heijden FL, Joost van Neerven RJ, van Katwijk M, Bos JD, Kapsenberg ML 1993. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol 150: 3643-3650.
105. Van Oosterhout AJ, Ladenius AR, Savelkoul HF, Van Ark I, Delsman KC, Nijkamp FP 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 147: 548-552.
106. van Rooijen N 1990. Antigen processing and presentation in vivo: the microenvironment as a crucial factor. Immunol Today 11: 436-439.
107. van Rooijen N 1992. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression. Semin Immunol 4: 237-245.
108. Wan H-C, Lazarovits AI, Cruikshank WW, Kornfeld H, Center DM, Weller PF 1995. Expression of α4β7 integrin on eosinophils and modulation of α4 integrin-mediated eosinophil adhesion via CD4. Int Arch Allergy Immunol 107: 343-344.
109. Wardlaw AJ, Kay AB 1992. Interrelationship between T lymphocytes and eosinophils, p. 261-271. In Eosinophils: biological and clinical aspects. Boca Raton, CRC Press.
110. Weg VB, Williams TJ, Lobb RR, Nourshargh S 1993. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 177: 561-566.
111. Weller PF 1991. The immunobiology of eosinophils. New Engl J Med 324: 1110-1118.
112. Weller PF 1993. Lipid, peptide and cytokine mediators elaborated by eosinophils, p. 25-42. In Immunopharmacology of eosinophils. The Handbook of immunopharmacology. London, Academic Press.
113. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW 1993. Accessory cell function of human eosinophils: HLA-DR dependent, MHC-restricted antigen-presentation and interleukin-1α formation. J Immunol 150: 2554-2562.
114. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RJ 1991. Human eosinophil adherence to vascular endothelium mediated by binding to VCAM-1 and ELAM-1. Proc Natl Acad Sci USA 88: 7430-7433.
115. 1. Blood 78: 2702-2707.
116. Wong DTW, Weller PF, Galli SJ, Rand TH, Elovic A, Chiang T, Chou MY, Gallagher GT, Matossian K, McBride J, Todd R 1990. Human eosinophils express transforming growth factor a. J Exp Med 172: 673-681.
117. Wyss-Coray T, Gallati H, Pracht I, Limat A, Mauri D, Frutig K, Pichler WJ 1993. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. Eur J Immunol 23: 3350-3357.
118. Xia W, Pinto CE, Kradin RL 1995. The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 181: 1275-1283.
119. Ying S, Meng Q, Taborda-Barata L, Corrigan CJ, Barkans J, Assoufi B, Moqbel R, Durham SR, Kay AB 1996. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 26: 70-76.